Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global pharmaceutical leader with a category-defying portfolio, harnessing our generics ...
TEVA is Emergent's biggest rival. TEVA was founded in Tel Aviv, Tel Aviv District} in 1901. Like Emergent, TEVA also competes in the Pharmaceuticals sector. Compared to Emergent, TEVA generates $16.5B more revenue.
Harm Reduction Therapeutics is Emergent's #3 competitor. Harm Reduction Therapeutics was founded in 2017 in , . Like Emergent, Harm Reduction Therapeutics also works within the Pharmaceuticals sector. Harm Reduction Therapeutics generates $ less revenue than Emergent.